Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Therapy of hepatitis C: patients with normal aminotransferase levels.

Hepatology (Baltimore, Md.) - 1 Sept 1997

Marcellin P, Lévy S, Erlinger S

Abstract excerpt

An important group of patients with chronic hepatitis C have normal serum alanine aminotransferase (ALT) levels despite having hepatitis C virus (HCV) RNA detectable in serum. These patients are typically identified after donating blood and being found to be positive for antibody to HCV (anti-HCV). A strict definition of this patient population is needed, which should include presence of anti-HCV, HCV RNA...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Genetic Variation
Share to Hepacivirus

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Hepatitis C

Share to Interferon-alpha

Share to Reference Values

Share to RNA, Viral

Source

Identifiers

PMID: 9305678
DOI: 10.1002/hep.510260723

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Therapy of hepatitis C: patients with normal aminotransferase levels.PMID 9305678Read ↗

Review article: management of patients with chronic hepatitis C virus infection and "normal" alanine aminotransferase activity.Semantic proximity Read ↗

Interferon monotherapy for patients with chronic hepatitis C and normal serum aminotransferase levels at commencement of treatment.Semantic proximity Read ↗

Interferon-alpha therapy for individuals with normal serum alanine aminotransferase levels before treatment.Semantic proximity Read ↗

Daily interferon monotherapy for chronic hepatitis C in patients with normal or near-normal serum alanine transaminase levels: a comparison of two protocols.Semantic proximity Read ↗

IFN-alpha2b monotherapy in patients with chronic hepatitis C and persistently normal or near normal aminotransferase activity: a randomized, controlled study.Semantic proximity Read ↗

Active disease in chronic hepatitis C patients with normal alanine aminotransferase.Semantic proximity Read ↗

Clinical management of HCV carriers with normal aminotransferase levels.Semantic proximity Read ↗

Efficacy of entecavir in chronic hepatitis B patients with persistently normal alanine aminotransferase: randomized, double-blind, placebo-controlled study.Semantic proximity Read ↗

Natural history of hepatitis C virus carriers with persistently normal aminotransferase levels.Semantic proximity Read ↗

Sustained virological response rates and health-related quality of life after interferon and ribavirin therapy in patients with chronic hepatitis C virus infection and persistently normal alanine aminotransferase levels.Semantic proximity Read ↗

Hepatitis C virus genotype 4 with normal transaminases: histological changes, schistosomiasis and response to treatment.Semantic proximity Read ↗

Long-term administration of natural interferon-alpha in patients with chronic hepatitis C: relationship to serum RNA concentration, HCV-RNA genotypes, histological changes and hepatitis C virus.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.